News | Radiation Dose Management | September 24, 2018

Acquisition adds RadiaDyne’s OARtrac real-time radiation dose monitoring platform, other technologies to AngioDynamics portfolio

September 24, 2018 — AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

This transaction expands AngioDynamics’ growing oncology business by adding RadiaDyne’s early-stage, proprietary OARtrac real-time radiation dose monitoring platform and other oncology solutions, including the IsoLoc/ImmobiLoc and Alatus balloon stabilizing technologies.

RadiaDyne’s recently launched OARtrac system provides precise, real-time measurement via a proprietary intracavitary device. The system delivers critical dose feedback to medical and radiation oncologists, providing customized adaptive radiotherapy, reduced side effects, and improved clinical outcomes across all forms of radiation and photon beam therapy.

RadiaDyne’s endorectal technology, IsoLoc/ImmobiLoc, removes transient rectal gas using a patented gas-release tip and reliably reduces prostate motion and radiation toxicity. RadiaDyne’s Alatus Vaginal Balloon Packing System provides physicians with an improved method for optimal dosimetry protection and decreased complications. Both patient-centric technologies improve clinical outcomes and are used widely in practice today.

RadiaDyne’s trailing 12-months revenues exceeded $6 million, and the acquisition is expected to close by the end of September and be neutral to earnings on an adjusted basis.

Deutsche Bank Securities Inc. served as the exclusive financial advisor to AngioDynamics.

For more information: www.angiodynamics.com

 

Related Content

Webinar | Radiation Dose Management

A holistic view of contrast and radiation dose data is imperative to help identify opportunities for clinical and ...

Time August 27, 2021
arrow
News | Radiation Dose Management

August 17, 2021 — Expert medical organizations caution that evidence-based ordering of medically necessary imaging exams ...

Time August 17, 2021
arrow
News | Computed Tomography (CT)

July 9, 2021—According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of ...

Time July 09, 2021
arrow
Feature | Computed Tomography (CT) | By Mikael Strindlund

Computed tomography (CT) imaging has broad diagnostic application and is the imaging gold standard for many clinical ...

Time July 02, 2021
arrow
News | Lung Imaging

April 30, 2021 — For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung ...

Time April 30, 2021
arrow
Feature | Radiation Dose Management | By Dave Fornell

More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S. population that was ...

Time March 04, 2021
arrow
News | Radiation Dose Management

February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND ...

Time February 05, 2021
arrow
News | Radiation Dose Management

December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose ...

Time December 11, 2020
arrow
News | Radiation Dose Management

August 3, 2020 — According to the new market research report "Radiation Dose Management Market by Products & Services ...

Time August 03, 2020
arrow
News | Computed Tomography (CT)

July 24, 2020 — A computed tomography (CT) scan technique that splits a full X-ray beam into thin beamlets can deliver ...

Time July 24, 2020
arrow
Subscribe Now